The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 03, 2025

Filed:

Jul. 23, 2020
Applicants:

Genentech, Inc., South San Francisco, CA (US);

Queen Mary University of London, London, GB;

Inventors:

Myles Lewis, London, GB;

Costantino Pitzalis, London, GB;

Nandhini Ramamoorthi, South San Francisco, CA (US);

Michael John Townsend, San Jose, CA (US);

Jason Hackney, San Carlos, CA (US);

Assignees:

Genentech, Inc., South San Francisco, CA (US);

Queen Mary University of London, London, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); A61K 31/519 (2006.01); A61P 19/02 (2006.01); C07K 16/28 (2006.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6883 (2013.01); A61K 31/519 (2013.01); A61P 19/02 (2018.01); C07K 16/2866 (2013.01); C07K 16/2887 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01);
Abstract

The present invention provides prognostic, predictive, and therapeutic methods for the treatment of rheumatoid arthritis (RA). The invention is based, at least in part, on the discovery that the expression level of one or more biomarkers described herein in a sample (e.g., a synovial tissue sample, a synovial fluid sample, or a combination thereof) from an individual having RA can be used in methods of determining whether an individual having RA is likely to exhibit disease progression, identifying an individual having RA who is likely to respond to a treatment including a disease modifying anti-rheumatic drug (DMARD), predicting responsiveness of an individual having RA to a treatment including a DMARD, selecting a therapy for an individual having RA, and treating an individual having RA, as well as related kits.


Find Patent Forward Citations

Loading…